Peter Schnuelle

TL;DR: Patients receiving a renal cadaveric transplantation have a substantial survival advantage over corresponding end-stage renal disease patients on the waiting list even in the setting of a single transplantation center where mortality on regular dialysis therapy was comparatively low.

TL;DR: Graft and patient survival were not negatively affected by the ESP allocation when compared to the standard allocation, and the ESP age matching of elderly donors and recipients is an effective allocation system for organs from elderly donors.

TL;DR: Donor pretreatment with low-dose dopamine reduces the need for dialysis after kidney transplantation and can be improved through pharmacological donor pretreatment to limit organ injury from cold preservation.

TL;DR: Optimizing the management of brain-dead organ donors, including the possibility of selective administration of adrenergic agents, may provide a major benefit on graft survival without adverse side effects for the recipients.

TL;DR: The data strongly suggest that the use of catecholamines in postmortal organ donors during intensive care results in immunomodulating effects and improves graft survival in long-term follow-up.